Listed

Anaptysbio, Inc

ANABNasdaqCIK 1370053HealthcareFiscal year ends Jun 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$27.5m, Q2 FY2026
Operating income$67.0m, Q2 FY2026
Net income$183.9m, Q2 FY2026
Anaptysbio, Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m3.3Revenue, Q3 FY2023, three months to 2023-09-30$3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figure9.0Revenue, Q4 FY2023, three months to 2023-12-31$9.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001193125-26-088290. Derived: 12-month figure less the 9-month figure.Report this figure7.2Revenue, Q1 FY2024, three months to 2024-03-31$7.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure11.0Revenue, Q2 FY2024, three months to 2024-06-30$11.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure30.0Revenue, Q3 FY2024, three months to 2024-09-30$30.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure43.1Revenue, Q4 FY2024, three months to 2024-12-31$43.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 12-month figure less the 9-month figure.Report this figure27.8Revenue, Q1 FY2025, three months to 2025-03-31$27.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure22.3Revenue, Q2 FY2025, three months to 2025-06-30$22.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure76.3Revenue, Q3 FY2025, three months to 2025-09-30$76.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure108Revenue, Q4 FY2025, three months to 2025-12-31$108.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 12-month figure less the 9-month figure.Report this figure25.6Revenue, Q1 FY2026, three months to 2026-03-31$25.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure27.5Revenue, Q2 FY2026, three months to 2026-06-30$27.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 6-month figure less the 3-month figure.Report this figure
Research and development$m30.9Research and development, Q3 FY2023, three months to 2023-09-30$30.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figurenot reported37.0Research and development, Q1 FY2024, three months to 2024-03-31$37.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure42.0Research and development, Q2 FY2024, three months to 2024-06-30$42.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure42.2Research and development, Q3 FY2024, three months to 2024-09-30$42.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figurenot reported41.2Research and development, Q1 FY2025, three months to 2025-03-31$41.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure37.8Research and development, Q2 FY2025, three months to 2025-06-30$37.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure31.4Research and development, Q3 FY2025, three months to 2025-09-30$31.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figurenot reportednot reportednot reported
Operating income$m(37.7)Operating income, Q3 FY2023, three months to 2023-09-30−$37.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figure(42.1)Operating income, Q4 FY2023, three months to 2023-12-31−$42.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001193125-26-088290. Derived: 12-month figure less the 9-month figure.Report this figure(42.2)Operating income, Q1 FY2024, three months to 2024-03-31−$42.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure(40.3)Operating income, Q2 FY2024, three months to 2024-06-30−$40.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure(22.8)Operating income, Q3 FY2024, three months to 2024-09-30−$22.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure171Operating income, Q4 FY2024, three months to 2024-12-31$171.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 12-month figure less the 9-month figure.Report this figure(27.5)Operating income, Q1 FY2025, three months to 2025-03-31−$27.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure(26.2)Operating income, Q2 FY2025, three months to 2025-06-30−$26.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure34.7Operating income, Q3 FY2025, three months to 2025-09-30$34.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure246Operating income, Q4 FY2025, three months to 2025-12-31$245.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 12-month figure less the 9-month figure.Report this figure(34.6)Operating income, Q1 FY2026, three months to 2026-03-31−$34.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure67.0Operating income, Q2 FY2026, three months to 2026-06-30$67.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 6-month figure less the 3-month figure.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figure(0.0)Income tax, Q4 FY2023, three months to 2023-12-31−$4.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-03, accession 0001193125-26-088290. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$9.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure0.1Income tax, Q4 FY2024, three months to 2024-12-31$149.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$44.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$39.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure0.7Income tax, Q4 FY2025, three months to 2025-12-31$689.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$40.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure(181)Income tax, Q2 FY2026, three months to 2026-06-30−$181.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 6-month figure less the 3-month figure.Report this figure
Net income$m(37.3)Net income, Q3 FY2023, three months to 2023-09-30−$37.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figure(42.2)Net income, Q4 FY2023, three months to 2023-12-31−$42.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-04-28, accession 0001193125-26-187044. Derived: 12-month figure less the 9-month figure.Report this figure(43.9)Net income, Q1 FY2024, three months to 2024-03-31−$43.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure(46.7)Net income, Q2 FY2024, three months to 2024-06-30−$46.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure(32.9)Net income, Q3 FY2024, three months to 2024-09-30−$32.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure(21.8)Net income, Q4 FY2024, three months to 2024-12-31−$21.8m. XBRL concept us-gaap:NetIncomeLoss. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 12-month figure less the 9-month figure.Report this figure(39.3)Net income, Q1 FY2025, three months to 2025-03-31−$39.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure(38.6)Net income, Q2 FY2025, three months to 2025-06-30−$38.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure15.1Net income, Q3 FY2025, three months to 2025-09-30$15.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure49.6Net income, Q4 FY2025, three months to 2025-12-31$49.6m. XBRL concept us-gaap:NetIncomeLoss. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 12-month figure less the 9-month figure.Report this figure(52.9)Net income, Q1 FY2026, three months to 2026-03-31−$52.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure184Net income, Q2 FY2026, three months to 2026-06-30$183.9m. XBRL concept us-gaap:NetIncomeLoss. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 6-month figure less the 3-month figure.Report this figure
Diluted EPS$ per share(1.41)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figurenot reported(1.64)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure(1.71)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure(1.14)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figurenot reported(1.28)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure(1.34)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure0.52Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figurenot reported(1.84)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figurenot reported
Basic EPS$ per share(1.41)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figurenot reported(1.64)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure(1.71)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure(1.14)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figurenot reported(1.28)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure(1.34)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure0.54Basic EPS, Q3 FY2025, three months to 2025-09-30$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figurenot reported(1.84)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figurenot reported

Balance sheet

Cash and equivalents$133.8m, FY2026
Shareholders' equity$10.6m, FY2026
Anaptysbio, Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31FY20262026-06-30
Cash and equivalents$m26.3Cash and equivalents, Q3 FY2023, at 2023-09-30$26.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-02, accession 0001370053-23-000065.Report this figure36.0Cash and equivalents, FY2023, at 2023-12-31$36.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0001370053-25-000024.Report this figure53.7Cash and equivalents, Q1 FY2024, at 2024-03-31$53.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001370053-24-000027.Report this figure71.8Cash and equivalents, Q2 FY2024, at 2024-06-30$71.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-05, accession 0001370053-24-000041.Report this figure192Cash and equivalents, Q3 FY2024, at 2024-09-30$191.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figure23.1Cash and equivalents, FY2024, at 2024-12-31$23.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure98.6Cash and equivalents, Q1 FY2025, at 2025-03-31$98.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure44.3Cash and equivalents, Q2 FY2025, at 2025-06-30$44.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure110Cash and equivalents, Q3 FY2025, at 2025-09-30$109.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure138Cash and equivalents, FY2025, at 2025-12-31$138.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure248Cash and equivalents, Q1 FY2026, at 2026-03-31$248.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure134Cash and equivalents, FY2026, at 2026-06-30$133.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure
Current assets$m428Current assets, Q3 FY2023, at 2023-09-30$428.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0001370053-23-000065.Report this figure407Current assets, FY2023, at 2023-12-31$406.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0001370053-25-000024.Report this figure372Current assets, Q1 FY2024, at 2024-03-31$372.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001370053-24-000027.Report this figure367Current assets, Q2 FY2024, at 2024-06-30$367.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-05, accession 0001370053-24-000041.Report this figure449Current assets, Q3 FY2024, at 2024-09-30$448.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figure432Current assets, FY2024, at 2024-12-31$431.9m. XBRL concept us-gaap:AssetsCurrent. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure363Current assets, Q1 FY2025, at 2025-03-31$363.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure292Current assets, Q2 FY2025, at 2025-06-30$291.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure331Current assets, Q3 FY2025, at 2025-09-30$330.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure350Current assets, FY2025, at 2025-12-31$350.3m. XBRL concept us-gaap:AssetsCurrent. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure316Current assets, Q1 FY2026, at 2026-03-31$316.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure198Current assets, FY2026, at 2026-06-30$198.4m. XBRL concept us-gaap:AssetsCurrent. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure
Total assets$m487Total assets, Q3 FY2023, at 2023-09-30$487.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0001370053-23-000065.Report this figure452Total assets, FY2023, at 2023-12-31$452.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0001370053-25-000024.Report this figure406Total assets, Q1 FY2024, at 2024-03-31$405.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001370053-24-000027.Report this figure427Total assets, Q2 FY2024, at 2024-06-30$427.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-05, accession 0001370053-24-000041.Report this figure493Total assets, Q3 FY2024, at 2024-09-30$493.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figure484Total assets, FY2024, at 2024-12-31$483.8m. XBRL concept us-gaap:Assets. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure422Total assets, Q1 FY2025, at 2025-03-31$422.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure335Total assets, Q2 FY2025, at 2025-06-30$335.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure353Total assets, Q3 FY2025, at 2025-09-30$353.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure364Total assets, FY2025, at 2025-12-31$364.4m. XBRL concept us-gaap:Assets. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure330Total assets, Q1 FY2026, at 2026-03-31$329.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure317Total assets, FY2026, at 2026-06-30$317.0m. XBRL concept us-gaap:Assets. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure
Current liabilities$m39.2Current liabilities, Q3 FY2023, at 2023-09-30$39.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0001370053-23-000065.Report this figure37.4Current liabilities, FY2023, at 2023-12-31$37.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0001370053-25-000024.Report this figure32.3Current liabilities, Q1 FY2024, at 2024-03-31$32.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001370053-24-000027.Report this figure40.4Current liabilities, Q2 FY2024, at 2024-06-30$40.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-05, accession 0001370053-24-000041.Report this figure43.9Current liabilities, Q3 FY2024, at 2024-09-30$43.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figure45.4Current liabilities, FY2024, at 2024-12-31$45.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure44.0Current liabilities, Q1 FY2025, at 2025-03-31$44.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure35.5Current liabilities, Q2 FY2025, at 2025-06-30$35.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure38.1Current liabilities, Q3 FY2025, at 2025-09-30$38.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure38.6Current liabilities, FY2025, at 2025-12-31$38.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure41.7Current liabilities, Q1 FY2026, at 2026-03-31$41.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure35.4Current liabilities, FY2026, at 2026-06-30$35.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure
Shareholders' equity$m120Shareholders' equity, Q3 FY2023, at 2023-09-30$120.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figure88.1Shareholders' equity, FY2023, at 2023-12-31$88.1m. XBRL concept us-gaap:StockholdersEquity. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure47.8Shareholders' equity, Q1 FY2024, at 2024-03-31$47.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure9.9Shareholders' equity, Q2 FY2024, at 2024-06-30$9.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure84.4Shareholders' equity, Q3 FY2024, at 2024-09-30$84.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure70.9Shareholders' equity, FY2024, at 2024-12-31$70.9m. XBRL concept us-gaap:StockholdersEquity. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure34.0Shareholders' equity, Q1 FY2025, at 2025-03-31$34.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure(44.7)Shareholders' equity, Q2 FY2025, at 2025-06-30−$44.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure(29.4)Shareholders' equity, Q3 FY2025, at 2025-09-30−$29.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure37.2Shareholders' equity, FY2025, at 2025-12-31$37.2m. XBRL concept us-gaap:StockholdersEquity. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure12.7Shareholders' equity, Q1 FY2026, at 2026-03-31$12.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure10.6Shareholders' equity, FY2026, at 2026-06-30$10.6m. XBRL concept us-gaap:StockholdersEquity. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure

Cash flow

Operating cash flow−$26.6m, Q2 FY2026
Capital expenditure$17.0k, Q1 FY2026
Share repurchases$0, Q2 FY2026
Anaptysbio, Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(36.5)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$36.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-05, accession 0001370053-24-000054. Derived: 9-month figure less the 6-month figure.Report this figure(34.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$34.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001193125-26-088290. Derived: 12-month figure less the 9-month figure.Report this figure(37.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$37.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure(21.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$21.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001370053-25-000064. Derived: 6-month figure less the 3-month figure.Report this figure(10.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$10.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001370053-25-000089. Derived: 9-month figure less the 6-month figure.Report this figure(66.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$66.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 12-month figure less the 9-month figure.Report this figure(10.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure(40.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$40.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 6-month figure less the 3-month figure.Report this figure(27.4)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$27.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001370053-25-000089. Derived: 9-month figure less the 6-month figure.Report this figure98.0Operating cash flow, Q4 FY2025, three months to 2025-12-31$98.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 12-month figure less the 9-month figure.Report this figure(25.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$25.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure(26.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$26.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$162.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-05, accession 0001370053-24-000054. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$280.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001193125-26-088290. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$27.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$33.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001370053-25-000064. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$35.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001370053-25-000089. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$263.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001193125-26-088290. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$35.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$39.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001370053-25-000064. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$12.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001370053-25-000089. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001193125-26-088290. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$17.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figurenot reported
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-05, accession 0001370053-24-000054. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-03, accession 0001193125-26-088290. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-06, accession 0001370053-25-000064. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-04, accession 0001370053-25-000089. Derived: 9-month figure less the 6-month figure.Report this figure0.5Share repurchases, Q4 FY2024, three months to 2024-12-31$456.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 12-month figure less the 9-month figure.Report this figure4.4Share repurchases, Q1 FY2025, three months to 2025-03-31$4.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure51.1Share repurchases, Q2 FY2025, three months to 2025-06-30$51.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 6-month figure less the 3-month figure.Report this figure9.7Share repurchases, Q3 FY2025, three months to 2025-09-30$9.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-04, accession 0001370053-25-000089. Derived: 9-month figure less the 6-month figure.Report this figure3.4Share repurchases, Q4 FY2025, three months to 2025-12-31$3.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure0.0Share repurchases, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-KT filed 2026-09-21, accession 0001193125-26-396696. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)28.69m, Q1 FY2026
Anaptysbio, Inc, shares, quarterly
Line itemUnitQ2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31
Diluted shares (weighted)m shares28.2Diluted shares (weighted), Q2 FY2022, three months to 2022-06-3028,204,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-07, accession 0001370053-23-000049.Report this figure28.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3028,289,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0001370053-23-000065.Report this figure28.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3127,953,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001370053-24-000027.Report this figure26.6Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3026,629,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-05, accession 0001370053-24-000041.Report this figure26.5Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3026,546,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0001370053-24-000054.Report this figure26.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3126,801,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-05, accession 0001370053-25-000046.Report this figure27.4Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3027,356,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure28.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3028,893,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure30.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3130,644,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure28.8Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3028,810,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001370053-25-000064.Report this figure29.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3029,018,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001370053-25-000089.Report this figure28.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3128,691,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219515.Report this figure

Shares outstanding: 29.90mShares outstanding, period not labelled, at 2026-09-1629,895,244 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-KT filed 2026-09-21, accession 0001193125-26-396696.Report this figure at Sep 16, 2026, from the cover of the 10-KT filed Sep 21, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.